Archives: Speakers

Rachael Pirrami went to school at the University of Toledo in Ohio where she got her B.S in Pharmaceutical Sciences, MBA, and PharmD. She worked as a Procurement and Logistics Pharmacy Intern at the Cleveland Clinic for 3 years and is now training as a Global Clinical Supply Chain Fellow at Takeda Pharmaceuticals. As a Fellow, she gets experience in all the various clinical supply chain areas including planning, operations, digital excellence, import and export, comparators and ancillaries, and vendor management.

Amy Raymond, PhD, PMP, is Executive Director and Therapeutic Strategy Lead with more than 25 years of experience in drug discovery and development. Her background includes progressive leadership roles in clinical operations and clinical strategy, with oncology clinical development experience spanning hematologic malignancies and solid tumors, rare to highly prevalent diseases, and all stages of the clinical development lifecycle.

In addition to her expertise in the unique dynamics of developing novel therapies for rare diseases, Dr. Raymond leads the Cell and Gene Therapy Hub at Worldwide Clinical Trials, leveraging a strong combination of scientific training and strategic leadership. Her development experience spans viral‑vectored gene therapies, TCR and CAR T-cell therapies for complex diseases, in vivo and ex vivo gene‑editing technologies, and a broad range of RNA‑based modalities. Her experiences confirm that understanding and aligning the needs of all stakeholders—patients and families, investigators and sites, regulators, and payers—is essential to delivering meaningful new therapies efficiently.

Dr. Raymond completed her doctoral training in molecular biology at University of California San Diego and post-doctoral training in molecular biology at Memorial Sloan-Kettering in New York City, New York, USA.

Susannah Streeter is a global financial commentator, Chief Investment Strategist at Wealth Club and an international keynote speaker and conference chair. She leads market and economic commentary at Wealth Club, helping investors build resilient portfolios, with a particular focus on long-term opportunities. As a former BBC Business Anchor, with 17 years on-air experience, Susannah has interviewed global CEOs, policymakers and world leaders, and has presented coverage from major international events. She also served as a Squadron Leader in the RAF Reserves, experience that continues to shape her approach to leadership and decision-making under pressure. Today, she works with organisations worldwide, delivering bespoke keynotes and chairing senior-level discussions that bring clarity, confidence, and perspective in uncertain times.

Dylan Chambers is a go-to-market leader focused on helping organisations realise the real potential of artificial intelligence. With experience at Microsoft, LinkedIn and Glint, he has spent his career working with high-growth technology companies and scaling teams across Europe. Most recently, he helped scale Pocketlaw (now Miramis), an AI-native contract management platform. Today at Laurel, Dylan works with professional services firms to transform how they capture time, improve productivity, and unlock revenue through AI. Passionate about the practical impact of emerging technology, he speaks about how organisations can move beyond the hype and successfully adopt AI to empower people and reshape the future of work.

Max is a pharmaceutical scientist and healthcare strategist with 15+ years of experience translating clinical evidence into real-world outcomes across biopharma, academia, and hospital systems.

He has led cross-functional teams supporting late-stage development and lifecycle strategy for therapies in oncology and immunology, with a focus on evidence generation, patient access, and responsible innovation.